Octagon Capital Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6M | Sell |
|
|||||
|
2025
Q1 | $45.8M | Sell |
|
|||||
|
2024
Q4 | $96M | Hold |
|
|||||
|
2024
Q3 | $86.7M | Buy |
|
|||||
|
2024
Q2 | $111M | Buy |
|
|||||
|
2024
Q1 | $165M | Hold |
|
|||||
|
2023
Q4 | $168M | Sell |
|
|||||
|
2023
Q3 | $119M | Buy |
|
|||||
|
2023
Q2 | $239M | Sell |
|
|||||
|
2023
Q1 | $214M | Buy |
|
|||||
|
2022
Q4 | $163M | Buy |
|
|||||
|
2022
Q3 | $171M | Sell |
|
|||||
|
2022
Q2 | $117M | Buy |
|
|||||
|
2022
Q1 | $119M | Buy |
|
|||||
|
2021
Q4 | $95.5M | Buy |
|
|||||
|
2021
Q3 | $52.6M | Buy |
|
|||||
|
2021
Q2 | $79.4M | Buy |
|
|||||
|
2021
Q1 | $23.5M | Hold |
|
|||||
|
2020
Q4 | $31.4M | Buy |
|